Entourage Health Corp. (ETRGF) Q2 2024 Earnings Call Transcript Summary
Entourage Health Corp. (ETRGF) Q2 2024 Earnings Call Transcript Summary
The following is a summary of the Entourage Health Corp. (ETRGF) Q2 2024 Earnings Call Transcript:
以下是Entourage Health corp.(ETRGF) 2024年第二季度業績會交易摘要:
Financial Performance:
金融業績：
Q2 2024 net revenue decreased by $0.9 million or 9% to $9.3 million year-over-year.
Adult-use channel revenue decreased by $1.7 million, or 29%, primarily due to softer demand and pricing pressures.
Gross profit before changes in fair value was $0.7 million for Q2 2024, a decrease of 67% from Q2 2023.
2024年第二季度淨營業收入同比減少90萬美元，降低9%，至930萬美元。
成人用途渠道收入減少170萬美元，或29%，主要是由於需求減弱和價格下壓。
2024年第二季度未計入公允價值變動的毛利潤爲70萬美元，較2023年第二季度減少67%。
Business Progress:
業務進展：
Expanded distribution of Dime Bag to over 90% in Ontario during Q2.
Launched four new SKUs in B.C., including Color Cannabis Live Resin pre-rolls and two new Color Cannabis 10-packs.
Increased focus on operational efficiencies and consumer-centric strategies to improve fiscal discipline and market performance.
Implemented strategic partnerships with third-party suppliers to ensure quality and consistent supply of products.
Leveraged data analytics to guide product development, distribution, and marketing decisions.
在第二季度，在安大略省Dime Bag擴大了分銷至90%以上。
在卑詩省推出了四款新SKU，包括Color Cannabis Live Resin預捲菸和兩款新的Color Cannabis 10包裝。
增加對業務效率和以消費者爲中心的策略的關注，以改善財政紀律和市場表現。
與第三方供應商實施戰略合作伙伴關係，確保產品質量和供應穩定。
利用數據分析指導產品開發、分銷和營銷決策。
Opportunities:
機會：
Focus on expanding distribution channels across major Canadian provinces and ensuring high-visibility location partnerships for product accessibility.
Introduction of innovative products like infused pre-rolls and large format flower to cater to diverse consumer needs, aiming to rapidly capitalize on emerging trends.
Formation of strategic partnerships to enhance product quality and supply consistency.
專注於擴大在加拿大主要省份的分銷渠道，並確保高知名度的位置合作伙伴關係，以提高產品可及性。
推出創新產品，如注入式預捲菸和大規格花朵，以滿足多樣化消費者需求，旨在迅速利用新興趨勢。
建立戰略合作伙伴關係，提高產品質量和供應穩定性。
Risks:
風險：
The cannabis industry's heightened competition, pricing pressures, and oversupply pose risks to revenue.
Volatile market conditions and evolving regulatory, economic, and consumer preference landscapes present challenges.
大麻股行業的競爭加劇、價格壓力和供應過剩對營業收入構成風險。
波動的市場環境和不斷變化的監管、經濟和消費者偏好環境帶來了挑戰。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。